Statistics for A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity
Total visits
| views | |
|---|---|
| A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity | 3 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 3 |
| November 2025 | 0 |
| December 2025 | 0 |